Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

70.32
Delayed Data
As of Mar 24
 +1.79 / +2.61%
Today’s Change
11.57
Today|||52-Week Range
74.94
+58.31%
Year-to-Date

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 75.00, with a high estimate of 86.00 and a low estimate of 36.00. The median estimate represents a +6.66% increase from the last price of 70.32.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.48
Sales
$5.2M
Reporting Date
May 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 19.02%
 
 
 
 
 
 
Growthannually 41.46%
 
 
 
 
 
 

Sales

Growthquarterly 6,578.01%
 
 
 
 
 
 
Growthannually 81,713.55%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.